Glaukos Corp.
(NYSE : GKOS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.56%93.070.6%$496.29m
TMOThermo Fisher Scientific Inc.
0.25%271.691.0%$394.12m
ABTAbbott Laboratories
1.76%76.960.8%$363.21m
BDXBecton, Dickinson and Company
0.49%235.151.1%$355.25m
ISRGIntuitive Surgical, Inc.
0.58%476.532.4%$348.45m
ALGNAlign Technology, Inc.
1.18%311.476.3%$317.13m
BSXBoston Scientific Corporation
1.80%38.471.1%$282.57m
ABMDABIOMED, Inc.
2.95%270.393.3%$264.26m
BAXBaxter International Inc.
0.12%75.121.7%$184.35m
EWEdwards Lifesciences Corporation
-0.34%169.401.2%$175.99m
SYKStryker Corporation
0.11%184.711.3%$175.49m
ZBHZimmer Biomet Holdings, Inc.
0.46%114.481.7%$139.88m
DXCMDexCom, Inc.
3.94%118.978.3%$126.53m
IDXXIDEXX Laboratories, Inc.
1.00%256.113.7%$125.32m
WATWaters Corporation
0.57%206.223.8%$118.73m

Company Profile

Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.